Entrar/Registro  
HOME SPANISH
 
Revista Médica de Costa Rica y Centroamérica
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista Médica de Costa Rica y Centroamérica >Year 2015, Issue 615


Stanford VL, Muñoz PA
Mastectomía contralateral profiláctica revisión de la evidencia actual
Rev Med Cos Cen 2015; 72 (615)

Language: Español
References: 20
Page: 265-269
PDF: 152.95 Kb.


Full text




ABSTRACT

Breast cancer is responsible for one third of cancers presented in women. (#1) Breast cancer in Costa Rica is the number one cause of death in the female population. (#12) Worldwide, it is estimated that 1.4 million women a year receive a diagnosis of breast cancer, while 458,000 die of the disease. On average, 1 in 8 women will be diagnosed with breast cancer in her lifetime, (#8) for this reason it is considered a matter of utmost importance and effect on the national agenda. There is not one identified factor but multiple risk factors associated with the development of breast cancer. In recent years the rates of contralateral prophylactic mastectomy have increased in patients with a history of breast cancer, but its role in the management of newly diagnosed patients remains controversial. (#14, #20)


Key words: No keywords


REFERENCIAS

  1. Berek JS. Berek y Novak Ginecología, Lippincott Williams & Wilkins, vol. 1, 15 a edición, 2012, Pp: 540-576

  2. Burke EE, Portschy PR, Tuttle TM. Prophylactic mastectomy: Who needs it, and why. Journal of Surgical Oncology. Jun 2014; Pp. 1-5

  3. Covelli AM, Baxter NN, Fitch MI, Wright FC. Increasing mastectomy rates- the effect of eviromental factor on the choice for mastectomy: a comparative analysis between Canada and the United States. Annals of Surgical Oncology. Aug 2014; Pp.3173-3184

  4. Fayanju OM, Stoll CR, Fowler S, Colditz GA, Margenthaler JA. Contralateral prophylatic Matectomy after unilateral breast cancer: A systematic review and meta-analysis. Annals of Surgery. Jun 2014; Pp. 1-11

  5. Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ. Social and clinical determinants of contralateral prophylactic mastectomy. The Journal of American Medical Association. May 2014; Pp. 582-589

  6. Jin J. Women with breast cáncer who opt for contralateral prophylactic mastectomy may overestimate future risk. Journal of American Medical Association. Oct 2013; Pp. 1548

  7. Katz SJ, Morrow M. Contralateral prophylatic mastectomy for breast cáncer: adressing peace of mind. Journal of American Medical Association. Aug 2013; Pp.793-794

  8. Kristen AB, Constantine VG. Epidemiology of Breast Cancer. Surgical Oncological Clinics of North America. Jan 2014; Pp. 409- 422

  9. Kruper L, Kauffmann RM, Smith DD, Nelson RA. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias. Annals of Surgical Oncology. Jul 2014; Pp. 3448-3456

  10. Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CE. Review of risk factors for the development of contralateral breast cáncer. The American Journal of Surgery. Nov 2013; Pp. 704-708

  11. Mayor S. Prophylatic mastectomy of contralateral breast only marginally improves survival, study shows. British Medical Journal. Jul 2014; Pp. 349

  12. Ministerio de Salud Costa Rica. Plan Nacional para la Prevención y Control del Cáncer 2011-2017, Ministerio de Salud, 1ª edición, 2012, Pp: 24-25

  13. Newman LA. Contralateral prophylatic mastectomy: is it a reasonable option. The Journal of American Medical Association. Sep 2014; Pp. 895-897

  14. Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K. Contralateral prophylatic mastectomy provides no suvival benefit in young women with estrogen receptor- negative breast cáncer. Annals of Surgical Oncology. Oct 2014; Pp.3231-3239

  15. Portschy PR, Kuntz KM, Tuttle TM. Survival outcomes after contralateral mastectomy: a decisión analysis. Journal of National Cancer Institute. Aug 2014; Pp.106-108

  16. Portschy PR, Tuttle TM. Contralateral prophylactic mastectomy: perceptions versus reality. Annals of Internal Medicine. Sep 2013; Pp. 428-429

  17. Roberts A, Habibi M, Frick KD. Cost-effectiveness of contralateral prophylatic mastectomy for prevention of contralateral breast cancer. Annals of Surgical Oncology. Jul 2014; Pp. 2209-2217

  18. Soran A, Kamali Polat A, Johnson R, McGuire KP. Increasing trend of contralateral prophylactic mastectomy: What are the factors behind this phenomenon?. The Surgeon, Journal of The Royal Colleges Of Surgeons of Edinburgh and Ireland. Mar 2014; Pp. 1-7

  19. Tracy MS, Rosenberg SM, Dominici L, Patridge AH. Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research. Breast Cancer Res Treat. Aug 2013; Pp. 447-452

  20. Yao K, Winchester DJ, Czechurz T, Huo D. Contralateral prophylactic mastectomy and survival: report from National Cancer Data Base, 1998-2002. Breast Cancer Res Treat. Nov 2013; Pp. 465-476






>Journals >Revista Médica de Costa Rica y Centroamérica >Year 2015, Issue 615
 

· Journal Index 
· Links 






       
Copyright 2019